Lightning Round: Powell Industries has been a 'big, big disappointment', says Jim Cramer In this video, I will install Trex composite deck boards. Big thanks to Trex Decking for Sponsoring this video ...

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

Barré syndrome, although it said data don’t prove a causal link and affirmed the shots’ benefit outweighs their risks.

Qualifire’s real-time AI control layer enables companies to deploy safer, more reliable LLM applications, ensuring compliance and reducing risks across industries.

Sana Biotechnology, Inc. shares surge as a breakthrough in diabetes therapy sparks investor interest. Click for my updated ...

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team ...

Orna will receive a $65m upfront payment and is eligible to receive potential milestone payments and royalties.

Good morning, Boston. Here are the five things you need to know in local business news to start your busy, frigid Wednesday.

Decentralized perp futures exchange Hyperliquid has changed the game for airdrops, handing out the largest airdrop in the ...

Finbold has selected three interesting pharmaceutical stocks that could see significant moves to the upside in 2025.

About four years after launch, Orna Therapeutics Inc. signed its second major deal, this time validating the lipid nanoparticle delivery technology it acquired through its Renagade Therapeutics Inc.

Vertex Pharmaceuticals Inc. closed $111.56 below its 52-week high ($519.88), which the company achieved on November 8th.